Literature DB >> 11754588

Design, synthesis, and discovery of novel trans-stilbene analogues as potent and selective human cytochrome P450 1B1 inhibitors.

Sanghee Kim1, Hyojin Ko, Jae Eun Park, Sungkyu Jung, Sang Kwang Lee, Young-Jin Chun.   

Abstract

A series of trans-stilbene derivatives containing a 3,5-dimethoxyphenyl moiety were prepared through a new efficient solution phase synthetic pathway, and their inhibitory activities were evaluated on human cytochrome P450s (CYP) 1A1, 1A2, and 1B1 to find a potent and selective CYP1B1 inhibitor. We found that a substituent at the 2-position of the stilbene skeleton plays a very important role in discriminating between CYP1As and CYP1B1. Among the compounds tested, the most selective and potent CYP1B1 inhibitor was 2,3',4,5'-tetramethoxystilbene. Compound 7j, 2-[2-(3,5-dimethoxy-phenyl)vinyl]thiophene, showed greater inhibitory activities but had a lower selectivity toward all of the CYP1s tested.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11754588     DOI: 10.1021/jm010298j

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

1.  Tetra-methoxystilbene modulates ductal growth of the developing murine mammary gland.

Authors:  Taehyun Kim; Hoyong Park; Wei Yue; Ji-Ping Wang; Kristen A Atkins; Zhenguo Zhang; Eleanor G Rogan; Ercole L Cavalieri; Khalid S Mohammad; Sanghee Kim; Richard J Santen; Sarah E Aiyar
Journal:  Breast Cancer Res Treat       Date:  2010-12-18       Impact factor: 4.872

2.  An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

Authors:  Joshua D Mezrich; John H Fechner; Xiaoji Zhang; Brian P Johnson; William J Burlingham; Christopher A Bradfield
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

3.  2,3',4,4',5'-Pentamethoxy-trans-stilbene, a resveratrol derivative, inhibits colitis-associated colorectal carcinogenesis in mice.

Authors:  Haitao Li; William Ka Kei Wu; Zhi Jie Li; Kam Ming Chan; Clover Ching Man Wong; Cai Guo Ye; Le Yu; Joseph Jao Yiu Sung; Chi Hin Cho; Mingfu Wang
Journal:  Br J Pharmacol       Date:  2010-07       Impact factor: 8.739

4.  Estrogen metabolism within the lung and its modulation by tobacco smoke.

Authors:  Jing Peng; Xia Xu; Brian E Mace; Lisa A Vanderveer; Laura R Workman; Michael J Slifker; Patrick M Sullivan; Timothy D Veenstra; Margie L Clapper
Journal:  Carcinogenesis       Date:  2012-12-31       Impact factor: 4.944

5.  Involvement of CYP1B1 in interferon γ-induced alterations of epithelial barrier integrity.

Authors:  Mireille Alhouayek; Sandra Gouveia-Figueira; Marie-Louise Hammarström; Christopher J Fowler
Journal:  Br J Pharmacol       Date:  2018-02-04       Impact factor: 8.739

Review 6.  Potential role of CYP1B1 in the development and treatment of metabolic diseases.

Authors:  Fei Li; Weifeng Zhu; Frank J Gonzalez
Journal:  Pharmacol Ther       Date:  2017-03-16       Impact factor: 12.310

7.  A Ligand-Based Drug Design. Discovery of 4-Trifluoromethyl-7,8-pyranocoumarin as a Selective Inhibitor of Human Cytochrome P450 1A2.

Authors:  Jiawang Liu; Peter T Pham; Elena V Skripnikova; Shilong Zheng; La'nese J Lovings; Yuji Wang; Navneet Goyal; Sydni M Bellow; Lydia M Mensah; Amari J Chatters; Melyssa R Bratton; Thomas E Wiese; Ming Zhao; Guangdi Wang; Maryam Foroozesh
Journal:  J Med Chem       Date:  2015-08-10       Impact factor: 7.446

8.  Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress.

Authors:  Daniel E Conway; Yumiko Sakurai; Daiana Weiss; J David Vega; W Robert Taylor; Hanjoong Jo; Suzanne G Eskin; Craig B Marcus; Larry V McIntire
Journal:  Cardiovasc Res       Date:  2009-01-06       Impact factor: 10.787

9.  CYP1A1 and 1B1-mediated metabolic pathways of dolutegravir, an HIV integrase inhibitor.

Authors:  Junjie Zhu; Pengcheng Wang; Feng Li; Jie Lu; Amina I Shehu; Wen Xie; Deborah McMahon; Xiaochao Ma
Journal:  Biochem Pharmacol       Date:  2018-10-17       Impact factor: 5.858

Review 10.  Targeting cytochrome P450 enzymes: a new approach in anti-cancer drug development.

Authors:  Robert D Bruno; Vincent C O Njar
Journal:  Bioorg Med Chem       Date:  2007-05-23       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.